SARS‐CoV‐2 targeting by RNAi and host complement inhibition: A two‐pronged subterfuge for COVID‐19 treatment

BACKGROUND: The lack of knowledge about the specific preventive measures and limited scientific information on severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) led to an excruciating onset and progression of coronavirus disease 2019 (COVID‐19). Swift development of various successful vac...

Descripción completa

Detalles Bibliográficos
Autores principales: Naqvi, Raza Ali, Shukla, Deepak, Naqvi, Afsar R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652782/
https://www.ncbi.nlm.nih.gov/pubmed/34644457
http://dx.doi.org/10.1002/iid3.549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652782/
https://www.ncbi.nlm.nih.gov/pubmed/34644457
http://dx.doi.org/10.1002/iid3.549

Ejemplares similares